Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7230012 | CELGENE | Pharmaceutical compositions and dosage forms of thalidomide |
Dec, 2023
(10 months from now) |
Market Authorisation Date: 16 July, 1998
Treatment: NA
Dosage: CAPSULE;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic